Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[13C]pantoprazole breath test as a predictor of the anti-platelet function of clopidogrel.

European journal of clinical pharmacology - 1 May 2010

Furuta Takahisa, Iwaki Takayuki, Umemura Kazuo

Abstract excerpt

BACKGROUNDS/AIMS: Clopidogrel, a platelet inhibitor, is metabolized by cytochrome P450 2C19 (CYP2C19) to its active metabolite and, consequently, its anti-platelet efficacy is influenced by CYP2C19 activity. The aim of this study was to determine whether the [(13)C]pantoprazole breath test, a recently developed tool used to measure CYP2C19 activity, can predict the anti-platelet efficacy of clopidogrel. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Pyridinylmethylsulfinylbenzimidazoles
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Breath Tests

Share to Carbon Isotopes

Share to Clopidogrel

Share to Feasibility Studies

Share to Platelet Aggregation

Share to Ticlopidine

Source

Identifiers

PMID: 20349052
DOI: 10.1007/s00228-010-0807-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

[13C]pantoprazole breath test as a predictor of the anti-platelet function of clopidogrel.PMID 20349052Read ↗

Prediction of clopidogrel low responders by a rapid CYP2C19 activity test.Semantic proximity Read ↗

Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test.Semantic proximity Read ↗

Is (+)-[13C]-pantoprazole better than (±)-[13C]-pantoprazole for the breath test to evaluate CYP2C19 enzyme activity?Semantic proximity Read ↗

Utility of the 13 C-pantoprazole breath test as a CYP2C19 phenotyping probe for children.Semantic proximity Read ↗

Stereoselective pharmacokinetics of stable isotope (+/-)-[13C]-pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity.Semantic proximity Read ↗

Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel.Semantic proximity Read ↗

Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.Semantic proximity Read ↗

Evaluation of Efficacy and Safety After Replacement of Methyl Hydrogen With Deuterium at 7-position Methyl Formate of ClopidogrelSemantic proximity Read ↗

Evaluation of efficacy and safety after replacement of methyl hydrogen with Deuterium at 7-position methyl formate of ClopidogrelSemantic proximity Read ↗

Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.